查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
成像市场报告：2030 年趋势、预测与竞争分析
市场调查报告书
商品编码
1356934

成像市场报告：2030 年趋势、预测与竞争分析

Bio-Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

成像趋势和预测

预计到 2030 年，全球成像市场将达到 170 亿美元，2024 年至 2030 年年复合成长率为 15.7%。该市场的主要驱动力是由于成像技术的进步、慢性病患病率上升和世界人口高龄化、诊断中心数量增加和放射性药物数量增加而对成像设备的需求增加。全球成像市场的未来充满希望，诊所、诊断中心、医院和实验室市场都有商机。

成像市场洞察

  • Lucintel 预测，由于 X 射线照相术在急诊医学、整形外科和普通放射学中的应用不断增加，预计在预测期内将实现最高增长。
  • 在这个市场中，由于基础设施和先进影像处理设备的重大发展使医院业务，医院将继续成为最大的细分市场。
  • 由于其完善的医疗保健系统、先进的医疗设施、不断增加的心臟疾病发病率以及较高的健康保险普及，预计北美在预测期内仍将是最大的地区，尤其是在美国。 。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球成像市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球成像市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球成像市场
    • 弹性成像
    • 磁振造影
    • 医学超音波或超音波检查
    • X射线摄影
  • 按技术分類的全球成像市场
    • 医学
    • 分子
  • 按最终用途分類的全球成像市场
    • 诊所
    • 诊断中心
    • 医院
    • 实验室

第4章2018-2030年分地区市场趋势及预测分析

  • 全球成像市场区域分布
  • 北美成像市场
  • 欧洲成像市场
  • 亚太生物成像市场
  • 其他区域成像市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球成像市场成长机会
    • 技术驱动的全球成像市场的成长机会
    • 按最终用途分類的全球成像市场成长机会
    • 按地区分類的全球成像市场成长机会
  • 全球成像市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球成像市场的产能
    • 全球成像市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Bioclinica
  • Bracco Imaging
  • FONAR
  • Bayer Healthcare Pharmaceuticals
  • Covidin corp
  • GE Healthcare
  • GammaMedica
简介目录

Bio-Imaging Trends and Forecast

The future of the global bio-imaging market looks promising with opportunities in the clinic, diagnostic center, hospital, and laboratory markets. The global bio-imaging market is expected to reach an estimated $17.0 billion by 2030 with a CAGR of 15.7% from 2024 to 2030. The major drivers for this market are increasing demand of bio imaging instrument as an advancements in the imaging technologies, rising prevalence of chronic diseases and aging world population, and increasing number of diagnostic centers and radiopharmaceuticals.

A more than 150-page report is developed to help in your business decisions.

Bio-Imaging by Segment

The study includes a forecast for the global bio-imaging by type, technology, end use, and region.

Bio-Imaging Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Elastography
  • Magnetic Resonance Imaging
  • Medical Ultrasonography or Ultrasound
  • X-Ray Radiography

Bio-Imaging Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Medical
  • Molecular

Bio-Imaging Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Clinics
  • Diagnostic Centers
  • Hospitals
  • Laboratories

Bio-Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bio-Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bio-imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bio-imaging companies profiled in this report include-

  • Bioclinica
  • Bracco Imaging
  • Fonar
  • Bayer Healthcare Pharmaceuticals
  • Covidin
  • GE Healthcare
  • Gammamedica

Bio-Imaging Market Insights

  • Lucintel forecasts that X-ray radiography is expected to witness highest growth over the forecast period due to its increasing adoption of emergency medicine, orthopedics, and general radiology.
  • Within this market, hospitals will remain the largest segment due to significantly growing developed infrastructure and advanced imaging facilities that enables hospitals to streamline their operations.
  • North America will remain the largest region during the forecast period due to presence of well-established healthcare systems, sophisticated medical facilities, increasing incidence of cancer and cardic diseases, and high adoption of healthcare insurance policies among the population particularly in the USA.

Features of the Global Bio-Imaging Market

  • Market Size Estimates: Bio-imaging market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Bio-imaging market size by type, technology, end use, and region. in terms of value ($B).
  • Regional Analysis: Bio-imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, technologies, end uses, and region.s for the bio-imaging market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bio-imaging market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the bio-imaging market size?

Answer: The global bio-imaging market is expected to reach an estimated $17.0 billion by 2030.

Q.2. What is the growth forecast for bio-imaging market?

Answer: The global bio-imaging market is expected to grow with a CAGR of 15.7% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the bio-imaging market?

Answer: The major drivers for this market are increasing demand of bio imaging instrument as an advancements in the imaging technologies, rising prevalence of chronic diseases and aging world population, and increasing number of diagnostic centers and radiopharmaceuticals.

Q.4. What are the major segments for bio-imaging market?

Answer: The future of the bio-imaging market looks promising with opportunities in the clinic, diagnostic center, hospital, and laboratory markets.

Q.5. Who are the key bio-imaging market companies?

Answer: Some of the key bio-imaging companies are as follows:

  • Bioclinica
  • Bracco Imaging
  • Fonar
  • Bayer Healthcare Pharmaceuticals
  • Covidin
  • GE Healthcare
  • Gammamedica

Q.6. Which bio-imaging market segment will be the largest in future?

Answer: Lucintel forecasts that X-ray radiography is expected to witness highest growth over the forecast period due to its increasing adoption of emergency medicine, orthopedics, and general radiology.

Q.7. In bio-imaging market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region during the forecast period due to presence of well-established healthcare systems, sophisticated medical facilities, increasing incidence of cancer and cardic diseases, and high adoption of healthcare insurance policies among the population particularly in the USA.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bio-imaging market by type (elastography, magnetic resonance imaging, medical ultrasonography or ultrasound, and X-ray radiography), technology (medical and molecular), end use (clinics, diagnostic centers, hospitals, and laboratories), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bio-Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bio-Imaging Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bio-Imaging Market by Type
    • 3.3.1: Elastography
    • 3.3.2: Magnetic Resonance Imaging
    • 3.3.3: Medical Ultrasonography or Ultrasound
    • 3.3.4: X-ray Radiography
  • 3.4: Global Bio-Imaging Market by Technology
    • 3.4.1: Medical
    • 3.4.2: Molecular
  • 3.5: Global Bio-Imaging Market by End Use
    • 3.5.1: Clinics
    • 3.5.2: Diagnostic Centers
    • 3.5.3: Hospitals
    • 3.5.4: Laboratories

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bio-Imaging Market by Region
  • 4.2: North American Bio-Imaging Market
    • 4.2.2: North American Bio-Imaging Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
  • 4.3: European Bio-Imaging Market
    • 4.3.1: European Bio-Imaging Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
    • 4.3.2: European Bio-Imaging Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
  • 4.4: APAC Bio-Imaging Market
    • 4.4.1: APAC Bio-Imaging Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
    • 4.4.2: APAC Bio-Imaging Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
  • 4.5: ROW Bio-Imaging Market
    • 4.5.1: ROW Bio-Imaging Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
    • 4.5.2: ROW Bio-Imaging Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bio-Imaging Market by Type
    • 6.1.2: Growth Opportunities for the Global Bio-Imaging Market by Technology
    • 6.1.3: Growth Opportunities for the Global Bio-Imaging Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bio-Imaging Market by Region
  • 6.2: Emerging Trends in the Global Bio-Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bio-Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bio-Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bioclinica
  • 7.2: Bracco Imaging
  • 7.3: FONAR
  • 7.4: Bayer Healthcare Pharmaceuticals
  • 7.5: Covidin corp
  • 7.6: GE Healthcare
  • 7.7: GammaMedica